Methodological Considerations on CYP2D6 Phenoconversion Due to Drug–Drug Interaction

Methodological Considerations on CYP2D6 Phenoconversion Due to Drug–Drug Interaction

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacology and therapeutics 2019-05, Vol.105 (5), p.1076-1076
Hauptverfasser: Ziesenitz, Victoria C., Mikus, Gerd
Format: Artikel
Sprache:eng
Schlagworte:
Cytochrome P-450 CYP2D6 - genetics
Drug Interactions
Genotype
Phenotype
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1076
container_issue 5
container_start_page 1076
container_title Clinical pharmacology and therapeutics
container_volume 105
creator Ziesenitz, Victoria C.
Mikus, Gerd
description
doi_str_mv 10.1002/cpt.1336
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2210225932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2210225932</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2496-9b69aa538d33ad7fe6ec9c090a2019ad017e4dd0e427111e29c095c3a117c4193</originalsourceid><addsrcrecordid>eNo9kE1OwzAQRi0EoqUgcQLkJZsUj52feonSApWK6KIgsbJce9oGpXGIE1B33IEbchIStbD6ZvS9mcUj5BLYEBjjN6ashyBEfET6EAkexJGIjkmfMSYDyUXcI2fev7VrKEejU9ITLBFSAPTJyyPWG2dd7taZ0TlNXeEzi5Wus3airqDp65yPYzrfYOGMKz6w8m1Fxw3S2tFx1ax_vr67oNOibg9Nd3lOTlY693hxyAF5vpss0odg9nQ_TW9nQclDGQdyGUutIzGyQmibrDBGIw2TTHMGUlsGCYbWMgx5AgDIuzIyQgMkJgQpBuR6_7es3HuDvlbbzBvMc12ga7ziHBjnkRS8Ra8OaLPcolVllW11tVN_Llog2AOfWY67_x6Y6hyr1rHqHKt0vuhS_AKxKG4o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2210225932</pqid></control><display><type>article</type><title>Methodological Considerations on CYP2D6 Phenoconversion Due to Drug–Drug Interaction</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ziesenitz, Victoria C. ; Mikus, Gerd</creator><creatorcontrib>Ziesenitz, Victoria C. ; Mikus, Gerd</creatorcontrib><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1002/cpt.1336</identifier><identifier>PMID: 30739311</identifier><language>eng</language><publisher>United States</publisher><subject>Cytochrome P-450 CYP2D6 - genetics ; Drug Interactions ; Genotype ; Phenotype</subject><ispartof>Clinical pharmacology and therapeutics, 2019-05, Vol.105 (5), p.1076-1076</ispartof><rights>2019 The Authors © 2019 American Society for Clinical Pharmacology and Therapeutics</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcpt.1336$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcpt.1336$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30739311$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ziesenitz, Victoria C.</creatorcontrib><creatorcontrib>Mikus, Gerd</creatorcontrib><title>Methodological Considerations on CYP2D6 Phenoconversion Due to Drug–Drug Interaction</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><subject>Cytochrome P-450 CYP2D6 - genetics</subject><subject>Drug Interactions</subject><subject>Genotype</subject><subject>Phenotype</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1OwzAQRi0EoqUgcQLkJZsUj52feonSApWK6KIgsbJce9oGpXGIE1B33IEbchIStbD6ZvS9mcUj5BLYEBjjN6ashyBEfET6EAkexJGIjkmfMSYDyUXcI2fev7VrKEejU9ITLBFSAPTJyyPWG2dd7taZ0TlNXeEzi5Wus3airqDp65yPYzrfYOGMKz6w8m1Fxw3S2tFx1ax_vr67oNOibg9Nd3lOTlY693hxyAF5vpss0odg9nQ_TW9nQclDGQdyGUutIzGyQmibrDBGIw2TTHMGUlsGCYbWMgx5AgDIuzIyQgMkJgQpBuR6_7es3HuDvlbbzBvMc12ga7ziHBjnkRS8Ra8OaLPcolVllW11tVN_Llog2AOfWY67_x6Y6hyr1rHqHKt0vuhS_AKxKG4o</recordid><startdate>201905</startdate><enddate>201905</enddate><creator>Ziesenitz, Victoria C.</creator><creator>Mikus, Gerd</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201905</creationdate><title>Methodological Considerations on CYP2D6 Phenoconversion Due to Drug–Drug Interaction</title><author>Ziesenitz, Victoria C. ; Mikus, Gerd</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2496-9b69aa538d33ad7fe6ec9c090a2019ad017e4dd0e427111e29c095c3a117c4193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cytochrome P-450 CYP2D6 - genetics</topic><topic>Drug Interactions</topic><topic>Genotype</topic><topic>Phenotype</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ziesenitz, Victoria C.</creatorcontrib><creatorcontrib>Mikus, Gerd</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ziesenitz, Victoria C.</au><au>Mikus, Gerd</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methodological Considerations on CYP2D6 Phenoconversion Due to Drug–Drug Interaction</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2019-05</date><risdate>2019</risdate><volume>105</volume><issue>5</issue><spage>1076</spage><epage>1076</epage><pages>1076-1076</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><cop>United States</cop><pmid>30739311</pmid><doi>10.1002/cpt.1336</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Clinical pharmacology and therapeutics, 2019-05, Vol.105 (5), p.1076-1076
issn 0009-9236
1532-6535
language eng
recordid cdi_proquest_miscellaneous_2210225932
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Cytochrome P-450 CYP2D6 - genetics
Drug Interactions
Genotype
Phenotype
title Methodological Considerations on CYP2D6 Phenoconversion Due to Drug–Drug Interaction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A09%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methodological%20Considerations%20on%20CYP2D6%20Phenoconversion%20Due%20to%20Drug%E2%80%93Drug%20Interaction&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Ziesenitz,%20Victoria%20C.&rft.date=2019-05&rft.volume=105&rft.issue=5&rft.spage=1076&rft.epage=1076&rft.pages=1076-1076&rft.issn=0009-9236&rft.eissn=1532-6535&rft_id=info:doi/10.1002/cpt.1336&rft_dat=%3Cproquest_pubme%3E2210225932%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2210225932&rft_id=info:pmid/30739311&rfr_iscdi=true